111 related articles for article (PubMed ID: 29432786)
1. Oleic acid induces the novel apolipoprotein O and reduces mitochondrial membrane potential in chicken and human hepatoma cells.
Weijler AM; Schmidinger B; Kapiotis S; Laggner H; Hermann M
Biochimie; 2018 Apr; 147():136-142. PubMed ID: 29432786
[TBL] [Abstract][Full Text] [Related]
2. Hepatosteatosis and estrogen increase apolipoprotein O production in the chicken.
Schmidinger B; Weijler AM; Schneider WJ; Hermann M
Biochimie; 2016 Aug; 127():37-43. PubMed ID: 27126072
[TBL] [Abstract][Full Text] [Related]
3. Microarray analysis provides new insights into the function of apolipoprotein O in HepG2 cell line.
Wu CL; Zhao SP; Yu BL
Lipids Health Dis; 2013 Dec; 12():186. PubMed ID: 24341743
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein O expression in mouse liver enhances hepatic lipid accumulation by impairing mitochondrial function.
Tian F; Wu CL; Yu BL; Liu L; Hu JR
Biochem Biophys Res Commun; 2017 Sep; 491(1):8-14. PubMed ID: 28647361
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid affects fatty acid and triglyceride metabolism in HepaRG cells exposed to fatty acids by different mechanisms.
Grünig D; Szabo L; Marbet M; Krähenbühl S
Biochem Pharmacol; 2020 Jul; 177():113860. PubMed ID: 32165129
[TBL] [Abstract][Full Text] [Related]
6. Dihydrocurcumin ameliorates the lipid accumulation, oxidative stress and insulin resistance in oleic acid-induced L02 and HepG2 cells.
Yu Q; Liu Y; Wu Y; Chen Y
Biomed Pharmacother; 2018 Jul; 103():1327-1336. PubMed ID: 29864915
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein O is mitochondrial and promotes lipotoxicity in heart.
Turkieh A; Caubère C; Barutaut M; Desmoulin F; Harmancey R; Galinier M; Berry M; Dambrin C; Polidori C; Casteilla L; Koukoui F; Rouet P; Smih F
J Clin Invest; 2014 May; 124(5):2277-86. PubMed ID: 24743151
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein O modulates cholesterol metabolism via NRF2/CYB5R3 independent of LDL receptor.
Chen J; Hu J; Guo X; Yang Y; Qin D; Tang X; Huang Z; Wang F; Hu D; Peng D; Yu B
Cell Death Dis; 2024 Jun; 15(6):389. PubMed ID: 38830896
[TBL] [Abstract][Full Text] [Related]
9. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
10. Oleic Acid Activates Mitochondrial Energy Metabolism and Reduces Oxidative Stress Resistance in the Pancreatic β-Cell Line INS-1.
Suzuki M; Endo K; Nagata R; Iida-Tanaka N
Biol Pharm Bull; 2024; 47(1):145-153. PubMed ID: 38171774
[TBL] [Abstract][Full Text] [Related]
11. Ablation of catalase promotes non-alcoholic fatty liver via oxidative stress and mitochondrial dysfunction in diet-induced obese mice.
Shin SK; Cho HW; Song SE; Bae JH; Im SS; Hwang I; Ha H; Song DK
Pflugers Arch; 2019 Jun; 471(6):829-843. PubMed ID: 30617744
[TBL] [Abstract][Full Text] [Related]
12. Astragaloside IV inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin-resistant HepG2 cells and triglyceride accumulation in oleic acid (OA)-treated HepG2 cells.
Zhou X; Wang LL; Tang WJ; Tang B
J Ethnopharmacol; 2021 Mar; 268():113556. PubMed ID: 33157223
[TBL] [Abstract][Full Text] [Related]
13. Kaempferol and Kaempferide Attenuate Oleic Acid-Induced Lipid Accumulation and Oxidative Stress in HepG2 Cells.
Tie F; Ding J; Hu N; Dong Q; Chen Z; Wang H
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445549
[TBL] [Abstract][Full Text] [Related]
14. The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells.
Izdebska M; Piątkowska-Chmiel I; Korolczuk A; Herbet M; Gawrońska-Grzywacz M; Gieroba R; Sysa M; Czajkowska-Bania K; Cygal M; Korga A; Dudka J
Can J Physiol Pharmacol; 2017 Dec; 95(12):1442-1453. PubMed ID: 28759727
[TBL] [Abstract][Full Text] [Related]
15. Influence of oleic acid in different solvent media on BRL 3A cell growth and viability.
Liu R; Yang W; Xia C; Chen Y; Gao S; Dong Z; Huang B; Li R; He P; Xu C
Acta Biochim Pol; 2018; 65(3):443-447. PubMed ID: 30212593
[TBL] [Abstract][Full Text] [Related]
16. Effects of daphnetin on lipid metabolism, insulin resistance and oxidative stress in OA‑treated HepG2 cells.
Liu Y; Liao L; Chen Y; Han F
Mol Med Rep; 2019 Jun; 19(6):4673-4684. PubMed ID: 30957185
[TBL] [Abstract][Full Text] [Related]
17. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis.
Patel TP; Rawal K; Soni S; Gupta S
Biomed Pharmacother; 2016 Oct; 83():785-791. PubMed ID: 27490779
[TBL] [Abstract][Full Text] [Related]
18. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.
Chen X; Li L; Liu X; Luo R; Liao G; Li L; Liu J; Cheng J; Lu Y; Chen Y
Life Sci; 2018 Jun; 203():291-304. PubMed ID: 29709653
[TBL] [Abstract][Full Text] [Related]
19. Plasma apolipoprotein O level increased in the patients with acute coronary syndrome.
Yu BL; Wu CL; Zhao SP
J Lipid Res; 2012 Sep; 53(9):1952-7. PubMed ID: 22693255
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein(a) synthesis and secretion from hepatoma cells is coupled to triglyceride synthesis and secretion.
Nassir F; Bonen DK; Davidson NO
J Biol Chem; 1998 Jul; 273(28):17793-800. PubMed ID: 9651381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
